What does CUSIP 004225108 represent in this 13F holders report?

CUSIP 004225108 is the security identifier for ACAD - ACADIA PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held ACAD - ACADIA PHARMACEUTICALS INC - Common Stock in Q1 2021?

258 institutional investors reported ACAD - ACADIA PHARMACEUTICALS INC - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

ACADIA PHARMACEUTICALS INC - Common Stock (ACAD)

CUSIP: 004225108

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 170,450,287
Total 13F shares: 145,061,195
Share change: -2,616,678
Total reported value: $3,742,096,150
Put/Call ratio: 211%
Price per share: $25.80
Number of holders: 258
Value change: -$221,828,762
Number of buys: 143
Number of sells: 158

Quarterly Holders Quick Answers

What is CUSIP 004225108?
CUSIP 004225108 identifies ACAD - ACADIA PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 004225108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ACAD - ACADIA PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAKER BROS. ADVISORS LP	13F	Company	25%	41,904,586	$2,240,219,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	11%	19,472,914	$1,041,023,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	6.2%	10,605,773	$566,984,000	—	31 Dec 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	4.6%	7,877,825	$421,149,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	4.2%	7,230,797	$386,560,000	—	31 Dec 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	3%	5,082,912	$271,735,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	1.5%	2,609,826	$139,521,000	—	31 Dec 2020	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	1.4%	2,391,842	$127,868,000	—	31 Dec 2020	13F
Palo Alto Investors LP	13F	Company	1.4%	2,301,477	$123,037,000	—	31 Dec 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	1.3%	2,242,800	$119,900,000	—	31 Dec 2020	13F
Avoro Capital Advisors LLC	13F	Company	1.1%	1,950,000	$104,247,000	—	31 Dec 2020	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.99%	1,679,739	$89,799,000	—	31 Dec 2020	13F
FIRST TRUST ADVISORS LP	13F	Company	0.95%	1,622,576	$86,743,000	—	31 Dec 2020	13F
Rock Springs Capital Management LP	13F	Company	0.95%	1,612,500	$86,204,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.85%	1,456,557	$77,868,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.83%	1,419,212	$75,871,000	—	31 Dec 2020	13F
Artisan Partners Limited Partnership	13F	Company	0.8%	1,358,670	$72,634,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.75%	1,273,029	$68,056,000	—	31 Dec 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.74%	1,265,510	$67,652,000	—	31 Dec 2020	13F
PFM Health Sciences, LP	13F	Company	0.74%	1,259,474	$67,331,000	—	31 Dec 2020	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.71%	1,209,077	$64,637,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	0.7%	1,192,615	$63,757,000	—	31 Dec 2020	13F
NORGES BANK	13F	Company	0.64%	1,092,532	$58,407,000	—	31 Dec 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.61%	1,046,611	$55,952,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.59%	1,011,090	$54,053,000	—	31 Dec 2020	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.56%	958,692	$51,252,000	—	31 Dec 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.55%	941,810	$50,349,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.5%	857,370	$45,835,000	—	31 Dec 2020	13F
MARSHALL WACE, LLP	13F	Company	0.5%	848,679	$45,370,000	—	31 Dec 2020	13F
THRIVENT FINANCIAL FOR LUTHERANS	13F	Company	0.46%	790,077	$42,237,000	—	31 Dec 2020	13F
GREAT POINT PARTNERS LLC	13F	Company	0.42%	720,502	$38,518,000	—	31 Dec 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.42%	710,432	$37,980,000	—	31 Dec 2020	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.38%	654,414	$34,985,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.38%	642,501	$34,349,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.35%	597,373	$31,935,000	—	31 Dec 2020	13F
SAMLYN CAPITAL, LLC	13F	Company	0.35%	593,165	$31,710,000	—	31 Dec 2020	13F
JENNISON ASSOCIATES LLC	13F	Company	0.34%	580,567	$31,037,000	—	31 Dec 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.34%	574,845	$30,731,213	—	31 Dec 2020	13F
Avidity Partners Management LP	13F	Company	0.31%	527,600	$28,205,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.3%	509,483	$27,237,000	—	31 Dec 2020	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.29%	486,000	$25,982,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.28%	477,175	$25,510,000	—	31 Dec 2020	13F
Neuberger Berman Group LLC	13F	Company	0.28%	470,900	$25,174,000	—	31 Dec 2020	13F
GREAT LAKES ADVISORS, LLC	13F	Company	0.26%	450,514	$24,084,000	—	31 Dec 2020	13F
Fairmount Funds Management LLC	13F	Company	0.26%	450,317	$24,074,000	—	31 Dec 2020	13F
Marshall Wace North America L.P.	13F	Company	0.25%	428,447	$22,906,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.25%	422,600	$22,592,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.22%	367,111	$19,626,000	—	31 Dec 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.2%	337,147	$18,025,000	—	31 Dec 2020	13F
Tekla Capital Management LLC	13F	Company	0.19%	331,789	$17,737,000	—	31 Dec 2020	13F

Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock (ACAD) as of Q1 2021

As of 31 Mar 2021, ACADIA PHARMACEUTICALS INC - Common Stock (ACAD) was held by 258 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 145,061,195 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, FMR LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., JANUS HENDERSON GROUP PLC, STATE STREET CORP, FRED ALGER MANAGEMENT, LLC, Avoro Capital Advisors LLC, and AMERIPRISE FINANCIAL INC. This page lists 258 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

298

Q1 2021 holders

258

Holder diff

-40

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.